Publication | Closed Access
Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer
150
Citations
38
References
2006
Year
Based on preclinical validation studies, IMC-18F1 anti-VEGFR-1 has potential to provide clinical benefit to cancer patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1